Q3 2025 ICU Medical Inc Earnings Call Transcript
Key Points
- ICU Medical Inc (ICUI) reported a 5% organic revenue growth in Q3 2025, with total revenue reaching $533 million.
- Gross margins improved, and operating expenses declined, leading to increased EBITDA and EPS.
- The Consumables business achieved record sales levels, driven by new global customer implementations and growth in niche markets.
- The IV Systems business saw a 9% reported growth, with strong contributions from LVP Pumps and dedicated sets.
- ICU Medical Inc (ICUI) successfully refinanced a portion of its credit facility, which is expected to save approximately $2 million annually in interest expenses.
- Reported revenue was negatively impacted by the deconsolidation of IV Solutions due to the Otsuka ICU Medical JV.
- Vital Care segment experienced a 52% decline in reported revenue, partly due to the deconsolidation of IV Solutions.
- Tariffs had a significant impact, with $11 million incurred in Q3, reducing the gross margin rate by approximately 2 percentage points.
- The company faces challenges in achieving its 45% gross margin target due to tariffs and other operational costs.
- Fourth-quarter growth rates are not expected to match the strong performance seen in Q3, particularly in the Consumables and IV Systems segments.
Good afternoon, everyone. Welcome to ICU Medical's third-quarter 2025 earnings conference call.
(Operator Instructions) Please note that today's event is being recorded.
I would now like to turn the conference over to Deirdre Thompson of ICR. Please go ahead.
Good afternoon, everyone. Thank you for joining us to discuss ICU Medical's financial results for the third quarter of 2025.
On the call today, representing ICU Medical, is Vivek Jain, Chief Executive Officer and Chairman; and Brian Bonnell, Chief Financial Officer.
We wanted to let everyone know that we have a presentation accompanying today's prepared remarks. To view the presentation, please go to our Investors page and click on Event Calendar. It will be under the Third-Quarter 2025 event.
Before we start our prepared remarks, I want to touch upon any forward-looking statements made during the call, including beliefs and expectations about the company's future results. Please be aware that they are based on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
